Showing results (151-160 of 193) with videos related to
Sort By:
Pageof 20
Molecular Imaging|April 25, 2014
Folate receptor–targeted single-photon emission computed tomography/computed tomography to detect activated macrophages in atherosclerosis: can it distinguish vulnerable from stable atherosclerotic plaques?Leah C J Winkel, Harald C Groen, Bibi S van Thiel, et al.Cancer Biotherapy & Radiopharmaceuticals|April 8, 2004
Molecular imaging and treatment of malignant gliomas following adenoviral transfer of the herpes simplex virus-thymidine kinase gene and the somatostatin receptor subtype 2 geneSuzanne M Verwijnen, Peter A E Sillevis Smith, Rob C Hoeben, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 10, 2016
68Ga/177Lu-NeoBOMB1, a Novel Radiolabeled GRPR Antagonist for Theranostic Use in OncologySimone U Dalm, Ingrid L Bakker, Erik de Blois, et al.European Journal of Nuclear Medicine and Molecular Imaging|September 6, 2002
Imaging expression of adenoviral HSV1-tk suicide gene transfer using the nucleoside analogue FIRUDharmin Nanda, Marion de Jong, Ronald Vogels, et al.European Journal of Nuclear Medicine and Molecular Imaging|May 13, 2022
In vitro dose effect relationships of actinium-225- and lutetium-177-labeled PSMA-I&TEline A M Ruigrok, Giulia Tamborino, Erik de Blois, et al.Pharmaceuticals (Basel, Switzerland)|July 29, 2023
[212Pb]Pb-eSOMA-01: A Promising Radioligand for Targeted Alpha Therapy of Neuroendocrine TumorsDylan Chapeau, Sofia Koustoulidou, Maryana Handula, et al.Endocrine-Related Cancer|December 10, 2009
Somatostatin-receptor-based imaging and therapy of gastroenteropancreatic neuroendocrine tumorsDik J Kwekkeboom, Boen L Kam, Martijn van Essen, et al.European Journal of Nuclear Medicine and Molecular Imaging|March 29, 2006
[(99m)Tc]Demotate 2 in the detection of sst(2)-positive tumours: a preclinical comparison with [(111)In]DOTA-tateTheodosia Maina, Berthold A Nock, Paul Cordopatis, et al.European Journal of Nuclear Medicine and Molecular Imaging|October 16, 2007
Targeting of a CCK(2) receptor splice variant with (111)In-labelled cholecystokinin-8 (CCK8) and (111)In-labelled minigastrinPeter Laverman, Susan Roosenburg, Martin Gotthardt, et al.European Journal of Nuclear Medicine and Molecular Imaging|August 11, 2022
Safety of [177Lu]Lu-NeoB treatment: a preclinical study characterizing absorbed dose and acute, early, and late organ toxicityEline A M Ruigrok, Marjolein Verhoeven, Mark W Konijnenberg, et al.Pageof 20